E. Koivunen

715 total citations
24 papers, 451 citations indexed

About

E. Koivunen is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, E. Koivunen has authored 24 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in E. Koivunen's work include Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (6 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). E. Koivunen is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (6 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). E. Koivunen collaborates with scholars based in Finland, United Kingdom and Sweden. E. Koivunen's co-authors include Kari Remes, P. Koistinen, T. Nousiainen, Liisa Volin, Maija Itälä, Timo Siitonen, Olof Selroos, Tapani Ruutu, Outi Kuittinen and Sirpa Leppä and has published in prestigious journals such as Blood, CHEST Journal and Leukemia.

In The Last Decade

E. Koivunen

24 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Koivunen Finland 14 252 129 102 89 89 24 451
R Rokicka-Milewska Poland 12 188 0.7× 56 0.4× 101 1.0× 59 0.7× 111 1.2× 55 490
P. Y. Le Prise France 10 285 1.1× 156 1.2× 137 1.3× 112 1.3× 25 0.3× 19 495
Pooja Khandelwal United States 15 417 1.7× 93 0.7× 74 0.7× 87 1.0× 65 0.7× 74 769
MA Boogaerts Germany 7 504 2.0× 150 1.2× 75 0.7× 157 1.8× 110 1.2× 10 668
Éric Hermet France 12 240 1.0× 214 1.7× 46 0.5× 84 0.9× 81 0.9× 31 548
A. Insunza Spain 9 163 0.6× 80 0.6× 82 0.8× 75 0.8× 60 0.7× 24 366
Ozay Halil United Kingdom 9 162 0.6× 60 0.5× 61 0.6× 59 0.7× 79 0.9× 14 368
C. N. Nair India 14 87 0.3× 120 0.9× 86 0.8× 42 0.5× 76 0.9× 41 493
Vedat Uygun Türkiye 13 174 0.7× 79 0.6× 48 0.5× 96 1.1× 85 1.0× 57 486
Paola Marenco Italy 11 350 1.4× 54 0.4× 39 0.4× 189 2.1× 67 0.8× 21 506

Countries citing papers authored by E. Koivunen

Since Specialization
Citations

This map shows the geographic impact of E. Koivunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Koivunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Koivunen more than expected).

Fields of papers citing papers by E. Koivunen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Koivunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Koivunen. The network helps show where E. Koivunen may publish in the future.

Co-authorship network of co-authors of E. Koivunen

This figure shows the co-authorship network connecting the top 25 collaborators of E. Koivunen. A scholar is included among the top collaborators of E. Koivunen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Koivunen. E. Koivunen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jantunen, Esa, Maija Itälä, Timo Siitonen, et al.. (2007). Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. Bone Marrow Transplantation. 41(3). 239–244. 16 indexed citations
2.
Mustjoki, Satu, Marja Ekblom, Auvo Rauhala, et al.. (2007). Clonal Large Granular Lymphocyte (LGL) Expansion Associated with Dasatinib Therapy.. Blood. 110(11). 2938–2938. 7 indexed citations
3.
Koistinen, Pirjo, Riikka Räty, Maija Itälä, et al.. (2007). Long‐term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML‐92 study by the Finnish Leukaemia Group. European Journal Of Haematology. 78(6). 477–486. 17 indexed citations
4.
Jantunen, Esa, Maija Itälä, Timo Siitonen, et al.. (2006). Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience. Bone Marrow Transplantation. 37(12). 1093–1098. 21 indexed citations
5.
Jantunen, Esa, Maija Itälä, Timo Siitonen, et al.. (2006). Late non‐relapse mortality among adult autologous stem cell transplant recipients: a nation‐wide analysis of 1482 patients transplanted in 1990–2003. European Journal Of Haematology. 77(2). 114–119. 22 indexed citations
6.
Jantunen, Esa, Maija Itälä, T. Lehtinen, et al.. (2006). Early treatment‐related mortality in adult autologous stem cell transplant recipients: a nation‐wide survey of 1482 transplanted patients. European Journal Of Haematology. 76(3). 245–250. 42 indexed citations
7.
Jantunen, Esa, E. Koivunen, Matti Putkonen, et al.. (2005). Autologous stem cell transplantation in patients with high‐risk plasmacytoma. European Journal Of Haematology. 74(5). 402–406. 11 indexed citations
8.
Jantunen, Esa, Juha Salonen, E. Koivunen, et al.. (2004). Invasive fungal infections in autologous stem cell transplant recipients: a nation‐wide study of 1188 transplanted patients. European Journal Of Haematology. 73(3). 174–178. 59 indexed citations
9.
Jantunen, Esa, Timo Siitonen, Matti Putkonen, et al.. (2004). Autologous Stem Cell Transplantation in Patients with Primary Amyloidosis: A Nation-wide Survey. Leukemia & lymphoma. 45(12). 2485–2489. 7 indexed citations
10.
11.
Oivanen, T., Pirkko Kellokumpu‐Lehtinen, A‐M. Koivisto, & E. Koivunen. (1999). Response rate and survival after conventional chemotherapy for multiple myeloma by hospitals with different inclusion rates of patients to the trials. A Finnish Leukemia Group study. European Journal Of Haematology. 63(4). 225–230. 3 indexed citations
12.
Oivanen, T., et al.. (1999). Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study. European Journal Of Haematology. 62(2). 109–116. 14 indexed citations
13.
14.
Elonen, Erkki, A. Almqvist, P. Koistinen, et al.. (1998). Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group. Leukemia. 12(7). 1041–1048. 35 indexed citations
15.
Ruutu, Tapani, Pirjo Koistinen, E. Koivunen, et al.. (1997). Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine. Leukemia Research. 21(2). 133–138. 28 indexed citations
16.
Palva, I. P., A. Almqvist, Erkki Elonen, et al.. (1991). Value of maintenance therapy with chemotherapy or interferon during remission of acute myeloid leukaemia. European Journal Of Haematology. 47(3). 229–233. 23 indexed citations
17.
Lehtinen, Maria K., et al.. (1988). [Deep venous thrombosis in a young athlete].. PubMed. 104(14). 1073–6. 4 indexed citations
18.
Pettersson, T, et al.. (1987). Sarcoidosis and multiple myeloma: an association.. BMJ. 295(6604). 958–958. 11 indexed citations
19.
Selroos, Olof, et al.. (1982). Cellular immunity during follow-up of patients with sarcoidosis of varying duration.. PubMed. 50(1). 25–33. 2 indexed citations
20.
Koivunen, E., Carola Grönhagen‐Riska, Matti Klockars, & Olof Selroos. (1981). Blood Monocytes and Serum and Bone Marrow Lysozyme in Sarcoidosis. Acta Medica Scandinavica. 210(1-6). 107–110. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Rokicka-Milewska Breakdown of academic impact, for papers by P. Y. Le Prise Breakdown of academic impact, for papers by Pooja Khandelwal Breakdown of academic impact, for papers by MA Boogaerts Breakdown of academic impact, for papers by Éric Hermet Breakdown of academic impact, for papers by A. Insunza Breakdown of academic impact, for papers by Ozay Halil Breakdown of academic impact, for papers by C. N. Nair Breakdown of academic impact, for papers by Vedat Uygun Breakdown of academic impact, for papers by Paola Marenco
Rankless by CCL
2026